Emergent Biosolutions Inc’s filing revealed that its Director DeGolyer Donald W unloaded Company’s shares for reported $0.27 million on Nov 12 ’24. In the deal valued at $10.91 per share,25,000 shares were sold. As a result of this transaction, DeGolyer Donald W now holds 111,100 shares worth roughly $1.1 million.
Then, White Marvin L sold 14,287 shares, generating $171,015 in total proceeds. Upon selling the shares at $11.97, the Director now owns 54,092 shares.
Before that, DeGolyer Donald W bought 25,000 shares. Emergent Biosolutions Inc shares valued at $294,250 were divested by the Director at a price of $11.77 per share.
H.C. Wainwright initiated its Emergent Biosolutions Inc [EBS] rating to a Buy in a research note published on December 30, 2024; the price target was $15. A number of analysts have revised their coverage, including Rodman & Renshaw’s analysts, who began to cover the stock in late August with a ‘”a Buy”‘ rating. The Benchmark Company also remained covering EBS and has increased its forecast on March 07, 2024 with a “Buy” recommendation from previously “Hold” rating.
Price Performance Review of EBS
On Friday, Emergent Biosolutions Inc [NYSE:EBS] saw its stock fall -2.08% to $9.88. Over the last five days, the stock has lost -3.80%. Emergent Biosolutions Inc shares have risen nearly 3.35% since the year began. Nevertheless, the stocks have risen 375.00% over the past one year. While a 52-week high of $15.10 was reached on 01/07/25, a 52-week low of $1.42 was recorded on 01/10/25. SMA at 50 days reached $9.32, while 200 days put it at $7.54.
Levels Of Support And Resistance For EBS Stock
The 24-hour chart illustrates a support level at 9.53, which if violated will result in even more drops to 9.19. On the upside, there is a resistance level at 10.10. A further resistance level may holdings at 10.33. The Relative Strength Index (RSI) on the 14-day chart is 58.09, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.85, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 24.83%. Stochastics %K at 80.00% indicates the stock is a holding.
How much short interest is there in Emergent Biosolutions Inc?
A steep rise in short interest was recorded in Emergent Biosolutions Inc stocks on 2024-12-13, growing by 0.12 million shares to a total of 6.94 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 6.81 million shares. There was a rise of 1.8%, which implies that there is a positive sentiment for the stock.
